Dear fellow executives,
Our company’s health care
division is being held back by the inefficiencies associated with the
traditional paper-based method of recording and archiving clinical trial
data. Our ‘time to lock’ process from
when we collect the final piece of trial data to the locking of our database is
approximately 8 weeks for our highest priority trials producing the fewest data
errors. Lesser priority or high issue
trials often take double or triple that time.
These ‘time to lock’ delays when considered over three to four clinical
trials ends up delaying our market entry times by 6 months to a year. Estimates predict that each day of delay in
market entry for a major prescription drug has the potential to cost us up to $1
million in lost sales. Time isn’t just money;
it’s the air that breathes life into the lungs of our health care business! The manual nature of the paper approach is
not only time consuming but also incredibly expensive. Each phase 3 trial we conduct costs us just
under $1 million in expenses related to printing, shipping and data entry for
CRF forms alone – at $9.25 per CRF page
and approximately 10,000 total pages. We
are paying our CRAs a handsome $2500 per site visit and the current process requires
more CRA visits than should be necessary. Much of the time they spend at sites is spent identifying
and ensuring the remediation of potential data errors. Phase 1 to 3 trials in total can cost us $125
million out of pocket and are consuming 7 full years of a valuable 20-year patent
life. We must make clinical trials more efficient
in terms of both time and cost. We can do
this is by adopting and carefully implementing web enabled Electronic Data
Capture (EDC).
Web enabled EDC is a new system that
utilizes the internet to allow data to be entered into the data management
system directly by the investigative sites.
This data will then immediately become available to us for monitoring
the trial and conducting blinded data analysis.
This approach will finally eliminate the need – and steep costs of associated
with — the ancient art of double data entry.
With several hundred error checks coded directly into the eCRFs, EDC will
provide automatic error checking. This
will allow investigators to identify and remediate potential data entry and patient
qualification errors on the spot and in real-time. This
has the additional benefit of early notification on trial difficulties and can
reduce the number of expensive onsite monitoring visits needed to be performed by
CRAs. We should opt to adopt the web
interfaced EDC largely because it will be less difficult for the investigators
to assimilate with, opposed to proprietary software. While there will definitely be a learning
curve associated with this switch, the fact that people are now becoming more
comfortable with the internet with everyday use should make the transition to
web based EDC less painful. Phase
Forward, our leading web based EDC provider candidate has agreed to include peripheral
services that include developing and maintaining the eCRFs as well as providing
help desk support for all our trial sites.
We have already conducted a handful of pilot trials with Phase Forward and
I am very impressed with the results. Our
data entry costs have been slashed by better than 50% from $6 to $9 per CRF
page down to only $3 to $4. That
translates to nearly $500,000 reduction in savings per trial. We
have realized an immediate positive impact on our ‘time to lock’. Each trial has become progressively more
efficient and by the fifth trial we had slashed the time to lock in half from 8
down to only 4 weeks. Recalling that each
day we gain potentially accounts for nearly $1 million in our top line sales,
this is a serious return – already $28 million per trial phase. And we believe we have the ability to drive
the time to lock progressively lower, perhaps eventually to but only a handful
of days.
Now without putting a serious
damper those appealing benefits I need to raise caution to the potential challenges
we may encounter with a transition to web enabled EDC. I also want to address the costs involved
with this investment. One of the
greatest hurdles will relate to resistance from users to adopting the new platform. People are still becoming familiar with the
internet and will be hesitant to adapt to a new process. Many will likely
require extensive customized training in order to become proficient with web
enabled EDC. Patients and site
administrators may have concerns about the privacy of their personal
information being recorded by an internet based application. While concerns may often be exaggerated, this
is an issue we must treat seriously as data security is critical. Occasionally slow or undependable internet
connections could delay data flows from time to time. Preparation times for trial set-up stages
could initially be much longer with EDC.
But we believe that as an experience curve develops these prep times
could be reduced to the same length of time as is customary with the paper
approach. While we are very impressed
with Phase Forward, the fact is they are a relatively young company lacking a
meaningful track record of success. There
will a leap of faith required in doing business with this company. There will be considerable upfront costs
associated with making sure all sites are fully equipped with the right
technical resources. We will need to
purchase laptop computers for approximately 750 of our sites which will cost
approximately $900,000. We can also
expect to pay around $500,000 in evaluations of all our sites to assess their
computing capabilities. After we have
covered these initial costs we can expect to pay Phase Forward a fee from
$250,000 to $450,000 per trial depending on the scope of the trial.
I have evaluated other options
that include bolstering the current paper system or alternatively adopting a
digital imaging system. By paying to
expedite the mailing of CRF binders and hiring additional staff members to
increase the speed of site monitoring and source data verification we could potentially
see a minor increase in the speed at which the current process moves. However, these actions would not address the
mechanical inefficiencies of the paper process which is inherently a tedious process. Innately there will always be limitations to
how fast this work can be performed by hand before significantly increasing the
incidence of errors. Digital imaging requires
substantial investments in large scale database storage systems. And after reviewing the digital imaging process
the results revealed that it did not considerably improve review times compared
to the paper process.
If we move quickly but carefully
we seek to gain a competitive advantage in the pharmaceutical industry. The upfront $1.4M investment and $250,000 to $450,000
in fees per trial can be more than offset by the immediate savings and
potential to significantly increase sales by reducing the time it takes us to
get to market. As previously stated, we
have already realized $500,000 savings per trial related to CRF related costs. We have already seen CRA visits slashed in
half translating to nearly $20,000 in savings per trial. We could expect to see a large reduction in
the $1,500 per site for fax related costs.
Compounded over time these collective savings are not to be
ignored. And the savings can grow as
experience helps enhance efficiencies. Web
based EDC will help us significantly reduce our time to lock and allow us to
get to market quicker than the 12 to 15 year average and allow us to squeeze additional
sales out of the remaining patent life. Web
enabled EDC has the ability to minimize the ‘time to lock’ for each of the
trial phases, potentially yielding an additional $360 in sales by getting us to
market a full year earlier! Web enabled
EDC is the move to make and the time is now!
Regards,
Bobby Grau
No comments:
Post a Comment